Adherium Ltd. Announces Quotation of Over 494 Million Securities on ASX
Adherium Ltd. has announced the quotation of over 494 million ordinary fully paid securities on the Australian Securities Exchange (ASX). This move aims to enhance the company's capital structure and strengthen its market position, providing new growth opportunities in the digital health sector. Adherium focuses on digital health technologies, particularly in monitoring and managing respiratory conditions. The current market cap is A$9.63M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Adherium Ltd. ( (AU:ADR) ) has issued an announcement.
Adherium Ltd. has announced the quotation of a significant number of ordinary fully paid securities on the Australian Securities Exchange (ASX), totaling over 494 million shares. This move is likely to enhance the company’s capital structure and potentially strengthen its market position, offering new opportunities for growth and development in the digital health sector.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare industry, focusing on digital health technologies. The company primarily provides solutions for monitoring and managing respiratory conditions, aiming to improve patient outcomes and reduce healthcare costs.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.63M
For an in-depth examination of ADR stock, go to TipRanks’ Overview page.
